Bwrdd Iechyd Prifysgol Betsi Cadwaladr University Health Board
Bwrdd Iechyd Prifysgol Hywel Dda University Health Board
Bwrdd Iechyd Addysgu Powys
Iechyd Cyhoeddus Cymru
Powys Teaching Health Board
Public Health Wales
Innovation and collaboration in NHS Wales
Studies across Wales trial convalescent plasma therapy for COVID-19
Ymddiriedolaeth GIG Felindre Velindre NHS Tust
Antibodies from patients who have recovered from COVID-19 are now being trialled as a possible treatment in two urgent public health research studies in Wales. It is hoped that the antibodies, contained within plasma collected from people who have already had COVID-19, could help people who are critically ill in hospital with the disease.
10
Ymddiriedolaeth GIG Gwasanaethau Ambiwlans Cymru Welsh Ambulance Services NHS Trust
This therapy, known as convalescent plasma, is being included in the RECOVERY and REMAP-CAP studies, alongside other drugs already being trialled. The UK-wide studies have been set up across Wales through Health and Care Research Wales.
Dr Matt Morgan, Health and Care Research Wales specialty lead for critical care, and Consultant in Intensive Care Medicine at the University Hospital of Wales, explained: “This involves giving the antibodies from patients in Wales who have already recovered from COVID-19 to patients who are critically ill. Much like giving blood, patients who recover can donate their antibodies in the form of plasma to help with the trials and hopefully help patients.
